Skip to content

Acadia Leadership

Our leaders bring deep expertise in neurological disorders and rare diseases, dedicating their careers to advancing care for those most in need.

Executive Leadership Team

Catherine Owen Adams
Thomas Garner
Jennifer J. Rhodes
Mark Schneyer
Elizabeth H.Z. Thompson, Ph.D.
Scott Cenci
Konstantina Katcheves
Carl Segerstrom

Board of Directors

Stephen Biggar, M.D., Ph.D.
Julian Baker
Laura Brege
James Daly
Elizabeth Garofalo, M.D.
Edmund Harrigan, M.D.
Adora Ndu, Pharm.D., J.D.
Catherine Owen Adams
Jonathan M. Poole

Featured Perspectives

From triumphs to challenges, we are promoting perspectives and driving discussion around the latest neuroscience topics. Read our insights and join the conversation.

Acadia Pharmaceuticals’ building illuminated in purple lights during the evening, showcasing modern architecture and vibrant ambiance
  • October 9, 2024
  • Acadia Story
Putting Commitment into Action for Rett Syndrome Awareness Month
Colorful papel picado banners hanging from the ceiling with string lights, creating a festive atmosphere
  • October 7, 2024
  • Acadia Story
Embracing My Heritage: Reflections on Hispanic Heritage Month
  • July 21, 2023
  • Employee Spotlight
Meet the Trailblazers: Holly Valdiviez

Important Note

You are now being redirected

You are now leaving acadia.com

You are about to leave acadia.com. You will be redirected to a third party website not affiliated with Acadia Pharmaceuticals Inc.
Do you want to continue?

You are leaving our {{LEAVING_REGION}} website and going to our {{ENTERING_REGION}} website, which is in {{ENTERING_LANGUAGE}}.
The information you are about to be referred to may not comply with the local regulatory requirements.
Do you want to continue?

You are now being directed to another Acadia website that contains information about specific treatment(s).
Do you want to continue?

Continue